
An expert at ESMO 2026 explains how liquid biopsy and ESR1 testing can help guide treatment for people with HR-positive metastatic breast cancer.
In this podcast, Nick Lenoir, who was diagnosed with multiple myeloma in 2016 at the young age of 31, shares his story.






